Cargando…

Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey

BACKGROUND: Limited studies have measured the burden of migraine in Japan. This study aimed at estimating the disease burden of migraine in Japan and identifying factors associated with the burden using the 2017 National Health and Wellness Survey. METHODS: Migraine patients were defined by ICHD-3 l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikui, Shoji, Chen, Yirong, Todaka, Hiroshi, Asao, Keiko, Adachi, Kenji, Takeshima, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488335/ https://www.ncbi.nlm.nih.gov/pubmed/32912187 http://dx.doi.org/10.1186/s10194-020-01180-9

Ejemplares similares

Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey
por: Kikui, Shoji, et al.
Publicado: (2022)

Burden of schizophrenia among Japanese patients: a cross-sectional National Health and Wellness Survey
por: Baba, Kenji, et al.
Publicado: (2022)

Migraine days and body mass index (BMI) in a series of Japanese migraineurs
por: Takeshima, T, et al.
Publicado: (2013)

Cranial autonomic symptoms in migraine are related to central sensitization: a prospective study of 164 migraine patients at a tertiary headache center
por: Danno, Daisuke, et al.
Publicado: (2022)

Chronic Cluster Headache with a Pediatric Onset: The First Japanese Case Report
por: Kikui, Shoji, et al.
Publicado: (2020)

Naratriptan May Become an Alternative Prophylactic Option for Patients with Cluster Headache
por: Kikui, Shoji, et al.
Publicado: (2017)

Clinical Profile of Chronic Cluster Headaches in a Regional Headache Center in Japan
por: Kikui, Shoji, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study
por: Suzuki, Keisuke, et al.
Publicado: (2021)

Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Matsumori, Yasuhiko, et al.
Publicado: (2021)

Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial
por: Takeshima, Takao, et al.
Publicado: (2022)

Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey
por: Igarashi, Hisaka, et al.
Publicado: (2020)

The safety and preventive effects of a supraorbital transcutaneous stimulator in Japanese migraine patients
por: Danno, Daisuke, et al.
Publicado: (2019)

Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
por: Tatsuoka, Yoshihisa, et al.
Publicado: (2021)

Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey
por: Arima, Kazuhiko, et al.
Publicado: (2018)

Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS)
por: Dissing, Agnete Skovlund, et al.
Publicado: (2023)

Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients
por: Sakai, Fumihiko, et al.
Publicado: (2021)

Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
por: Kitamura, Shigekazu, et al.
Publicado: (2023)

A Combination of Indomethacin Farnesyl and Amitriptyline Is Effective for Continuous Interictal Pain with Probable Chronic Paroxysmal Hemicrania
por: Kikui, Shoji, et al.
Publicado: (2021)

Development and Validation of a Japanese-Language Questionnaire to Screen for Tension-Type Headaches and Migraines
por: Tanobe, Kaho, et al.
Publicado: (2023)

A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults
por: Sakai, Fumihiko, et al.
Publicado: (2019)

Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
por: Saigoh, Kazumasa, et al.
Publicado: (2023)

Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials
por: Saigoh, Kazumasa, et al.
Publicado: (2023)

Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature
por: Takeshima, Takao, et al.
Publicado: (2019)

Decomposition of gender differences in cognitive functioning: National Survey of the Japanese elderly
por: Okamoto, Shohei, et al.
Publicado: (2021)

Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine
por: Sakai, Fumihiko, et al.
Publicado: (2021)

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries
por: Doane, Michael J., et al.
Publicado: (2020)

A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey
por: Ding, Bo, et al.
Publicado: (2017)

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients
por: Takeshima, Takao, et al.
Publicado: (2022)

Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort: Results from ‘Migraine in Poland’—a nationwide cross-sectional survey
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

Clinical and Humanistic Burden of Atopic Dermatitis in Europe: Analyses of the National Health and Wellness Survey
por: Luger, Thomas, et al.
Publicado: (2022)

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey
por: McGarvey, Lorcan, et al.
Publicado: (2023)

Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
por: Hirata, Koichi, et al.
Publicado: (2023)

The global burden of migraine
por: Lipton, Richard B., et al.
Publicado: (2003)

Leptin Level and Skipping Breakfast: The National Health and Nutrition Examination Survey III (NHANES III)
por: Asao, Keiko, et al.
Publicado: (2016)

Weight Change and All-Cause Mortality in Later Life: Findings From the National Survey of the Japanese Elderly
por: Murayama, Hiroshi, et al.
Publicado: (2020)

Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study
por: Takeshima, Takao, et al.
Publicado: (2021)

Japanese National Questionnaire Survey in 2018 on Complications Related to Cranial Implants in Neurosurgery
por: YASUHARA, Takao, et al.
Publicado: (2020)

Burden of migraine in a Kuwaiti population: a door-to-door survey
por: Al-Hashel, Jasem Yousef, et al.
Publicado: (2017)

Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey
por: Nomura, Shuhei, et al.
Publicado: (2021)

Association between sleep quality, migraine and migraine burden
por: Duan, Shaojie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jb6j10g4vq0tfn8lg4begtkb17